Patent · US Expired

Induction of tumour immunity by injection of hybrid cells

US6007807A · kind A · utility

2Cited by

0References

15Claims

0Family size

Assignee

GSF FORSCHUNGSZENTRUM FUR UMWELT UND GESUNDHEIT GMBH · DE

Inventors

Ralf Mocikat · Munich, DE
Horst Lindhofer · Puchheim, DE
Stefan Thierfelder · Eichenau, DE

Key dates

Filing date	Aug 25, 1997
Grant date	Dec 28, 1999
Priority date	—
Expiry date	Aug 25, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/5156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A hybrid fusion cell comprising: PA1 a) a malignant B cell which expresses an idiotypic antibody; and PA1 b) a hybridoma which expresses an antibody which is capable of being internalized on a professional antigen presenting cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.